A randomized controlled clinical trial to evaluate the effect Of medhya rasayana in premenstrual dysphoric disorder in college going Students
试验速览
- 阶段
- 2/3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Medhya rasayana may have impact on reducing total DRSP Score.
研究概览
简要总结
Premenstrual dysphoric disorder is a chronic disorder expected to last until menopause, long-term safety of
therapeutic interventions is a major concern. So, it is the need of hour to find out an
easily accessible and inexpensive treatment with minimal side effect
Medhya rasayana is having the property of improving mental health (Medhya),
correcting Agni (Agni vardhana), as well as curing the disease (Amaya nashini) can be
considered as a drug of choice in Premenstrual dysphoric disorder (PMDD) as mental as well as physical well-being is
affected in premenstrual dysphoric disorder
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 26.00 Year(s)(—)
- 性别
- Female
入选标准
- •College going female students age ranging from 18 to 26 years Regular menstruation of 28-to-35-day cycle Those who satisfy the diagnostic criteria as per DSM-5 criteria for PMDD; and those who complete the DRSP Questionnaire for 2 consecutive cycles.
排除标准
- •Participants with other psychiatric disorders (Psychosis, bipolar disorder, Anxiety disorder,OCD).
- •PMDD Participants with suicidal tendency/ thought Participants with severe dysmenorrhea Participants with irregular period and absence of menstruation for 3 consecutive cycles Those who are under medication for PMDD Those who are having premenstrual syndrome Those who are on Oral contraceptives Those who need immediate medical care Known cases of Type 2DM, Hypertension, Autoimmune disorders.
结局指标
主要结局
Medhya rasayana may have impact on reducing total DRSP Score.
时间窗: 90DAYS
次要结局
- To improve academic performance(30th day, 60th day, 90th day)
研究者
SOUMYA E A
G J Patel Institute Of Ayurvedic Studies And Research
